Doctors are prescribing mushrooms to cancer patients to treat anxiety



The results of the first study on LSD used in drug therapy were announced last month, hinting at the benefits of psychedelics substances used in treating patients with anxiety.

Now, according to The Atlantic, similar research is being conducted at New York University, as scientists test psilocybin mushrooms as a means of treating anxious cancer patients.

Like LSD, psilocybin mushrooms are Schedule I substances regulated under the Controlled Substances Act of 1970, putting stringent restrictions on scientific study. Nevertheless, after going through all the requisite safeguards on their work, researchers are seeing some patients benefit from the treatment — especially with regard to their coping with terminal illness.

While their data is still being analyzed, the work already shows promise for future study into hallucinogens.

Read the whole article at The Atlantic.

Source: The Verge - Read the original article here

Author: Daily Tech Whip

This article is part of our 'News Tiles' service. The site is currently in Beta. When it is fully operational you will be able to search through and arrange the 'Tiles' to display a keyword, product or technology over your chosen time period. For example you would be able to display all of the leading tech articles on the new Kindle Fire, in one spot in real time. You will also have access to our own original reporting and analysis as well as a polished place to post your own thoughts & reviews here, amongst the Daily Tech Whip Community. Please let us know if you have any feedback via the contact form or via Twitter. Don't forget to come back next week and see our full site and claim your name and your own free tech blog.

Share This Post On